Seller record · peptidelabsusa.com

Peptide Labs USA

Recorded September 2026 · Standard v1.1

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed on any page read, and the stated purchase conditions are a minimum age of twenty one and a self-asserted research qualification. 3 more criteria also fail; see the table below.

Research vendor. Passes 3 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A research peptide seller offering vials of NAD+, glutathione and repair peptides at prices printed on its catalog. Its checkout asks the buyer to agree to the terms of service of a differently named company, and the two are reconciled on no page read.

Operating entity The footer, the contact page and the terms of service were all read, and none of the three prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	peptidelabsusa.com/terms
S2	Prescription gating	FAIL	peptidelabsusa.com/checkout
S3	Pharmacy identification	FAIL	peptidelabsusa.com/terms
S4	Compounding disclosure	PASS	peptidelabsusa.com/terms
S5	Analytical documentation	NOT VERIFIED	peptidelabsusa.com/coa
S6	Business address	FAIL	peptidelabsusa.com/contact-us
S7	Price disclosure	PASS	peptidelabsusa.com/products
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician evaluation is claimed on any page read, and the stated purchase conditions are a minimum age of twenty one and a self-asserted research qualification.Source: peptidelabsusa.com/terms.

S2FAILA checkout collects full name, email, telephone and address with no eligibility question. The path was walked from the NAD+ page at 59 dollars.Source: peptidelabsusa.com/checkout.

S3FAILNo pharmacy is named on any page read, and the terms sell every product for research use only.Source: peptidelabsusa.com/terms.

S4PASSThe seller offers no compounded drug, and the terms state that the products are for lawful research use only and not for human consumption.Source: peptidelabsusa.com/terms.

S5NOT VERIFIEDThe certificate documents behind the purity and endotoxin controls on the certificate page did not resolve, because those controls returned nothing when driven and expose no document address. The check is open.Source: peptidelabsusa.com/coa.

S6FAILThe footer, the contact page and the terms were read, the contact page offers a form and a telephone number, and the terms name a state of jurisdiction in place of any street address.Source: peptidelabsusa.com/contact-us.

S7PASSThe catalog prints prices with no account required, among them 59 dollars for NAD+ and figures from 39 dollars upward across the range.Source: peptidelabsusa.com/products.

S8PASSNo letter names the storefront in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including BPC-157, CJC-1295 and cagrilintide, NAD+, L-glutathione, AOD-9604, melanotan II, PT-141.

Sellers passing S1, prescriber requirement

Records dated September 2026

Records dated August 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.